Table 4.
Levels of OS/inflammation-related indicators in different group ().
| Groups | IL-17 (pg/mL) | IL-23 (ng/L) | ROS (U/mL) | MDA (nmol/mL) | SOD (U/mL) | CAT (U/mL) | GSH (μmol/L) |
|---|---|---|---|---|---|---|---|
| Normal group | 11.25 ± 0.19 | 38.32 ± 0.37 | 311.36 ± 3.33 | 9.56 ± 0.48 | 24.52 ± 0.27 | 95.53 ± 0.38 | 61.49 ± 0.46 |
| Model group | 21.53 ± 0.96# | 44.49 ± 0.83# | 386.93 ± 6.87# | 18.41 ± 0.60# | 22.39 ± 0.26# | 39.87 ± 0.44# | 28.28 ± 0.33# |
| Low-dose PCs group | 16.51 ± 1.06∗& | 35.24 ± 0.28∗& | 343.05 ± 5.96∗& | 15.47 ± 0.42∗& | 23.35 ± 0.33∗& | 55.62 ± 0.31∗& | 44.52 ± 1.00∗& |
| Medium-dose PCs group | 10.53 ± 0.51∗& | 37.32 ± 0.55∗& | 336.57 ± 8.37∗& | 12.63 ± 0.49∗& | 23.64 ± 0.16∗& | 62.66 ± 0.34∗& | 57.40 ± 0.49∗& |
| High-dose PCs group | 9.96 ± 0.43∗& | 36.94 ± 0.49∗& | 332.15 ± 1.44∗& | 8.59 ± 0.45∗& | 24.13 ± 0.92∗& | 61.61 ± 0.24∗& | 47.80 ± 0.88∗& |
| Control group | 21.92 ± 0.89# | 43.65 ± 0.56# | 383.42 ± 9.62# | 19.26 ± 0.59# | 22.40 ± 0.26# | 38.59 ± 0.63# | 27.91 ± 0.25# |
Note: compared with the normal group, #p < 0.05; compared with the model group, ∗p < 0.05; and compared with the control group, &p < 0.05.